Skip to content
DataLookout
Menu

NCT07760727

High-Flow Nasal Oxygyen Therapy During Sedated Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration(EBUS-TBNA)

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 6 words Show 4 more changesShow less
    • Completed without a posted recruiting period
    • Study completion date changed from estimate of Nov 20, 2026 to Oct 20, 2026
    • Site contact updated
    • Publications: details revised at 1 of 1 entry
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Respiratory Complications
Timeframe: During the procedure

Secondary (5)

Oxygen partial pressure (PaO2)
Carbon dioxide partial pressure (PvCO2)
Venous pH
Venous Oxygen Saturation (SvO2)
Recovry Time

Arms and interventions

Group H (High-Flow Nasal Oxygen Group)

Patients undergoing sedated EBUS-TBNA who receive high-flow nasal oxygen therapy during the procedure. Respiratory complications, oxygenation parameters, blood gas values, and post-procedural recovery outcomes are evaluated.

Group C (Conventional Oxygen Group)

Patients undergoing sedated EBUS-TBNA who receive conventional oxygen therapy during the procedure. Respiratory complications, oxygenation parameters, blood gas values, and post-procedural recovery outcomes are evaluated.

Devices: High-Flow Nasal Oxygen Therapy, Conventional Oxygen Therapy

Sites

1 site in 1 country

  • Ankara Dr. Abdurrahman Yurtaslan Oncolgy Training and Research HospitalAnkara, Central, Turkey (Türkiye)